Healthcare Industry News:  Accuray 

Devices Oncology

 News Release - June 20, 2006

Number of CyberKnife(R) Systems Installed in the U.S. More Than Doubles in Less Than One Year

Accuray Installs 75th CyberKnife System Worldwide and 50th in the U.S.

SUNNYVALE, Calif.--(HSMN NewsFeed)--June 20, 2006--Accuray Incorporated, the global leader in the field of robotic radiosurgery, announced today that it has more than doubled the number of CyberKnife® Robotic Radiosurgery Systems installed in the United States in less than one year. To date, Accuray has installed 50 CyberKnife Systems in the U.S. and 75 systems worldwide. Also, an additional 50 CyberKnife Systems have been acquired by medical centers throughout the world and are pending installation. Now, patients with some of the most difficult to treat cancers of the spine, lung, liver, prostate and pancreas have access to expanded radiosurgery treatment options. The 50th installation in the U.S., WellStar Kennestone Hospital in Marietta, Georgia, is the first medical center in that state to install a CyberKnife System, bringing cancer patients in the state of Georgia the benefits of robotic radiosurgery for the first time ever.

"The WellStar Kennestone Hospital's installation of the CyberKnife System is an important addition to the hospital's recently expanded cancer center as it brings the vital option of advanced robotic radiosurgery to cancer patients throughout the state of Georgia," said Don Burton, Executive Director, Oncology Services, WellStar Kennestone Hospital. "We believe our patients -- particularly those with complex or difficult to treat tumors in the brain, spine, lung and prostate -- will immediately begin to benefit from the CyberKnife System's ability to treat tumors effectively and with a high degree of patient comfort."

According to the World Health Organization, more than 7.6 million people die from cancer annually. Some of the lowest survival rates are for patients with cancer in the lung, pancreas and liver, areas that are the most challenging to treat because the tumors move with respiration. A key differentiating feature of the CyberKnife System is the Synchrony(TM) Respiratory Tracking System. As the first and only technology designed to track, detect and correct for tumor and patient movement throughout the treatment, Synchrony is designed to minimize damage to surrounding healthy tissue and critical structures and allows patients to breathe normally without breath-holding or gating techniques.

"With the number of CyberKnife Systems doubling in less than one year, clearly clinicians recognize that the CyberKnife System meets a critical need in the treatment of their cancer patients," said Euan Thomson, president and chief executive officer of Accuray. "With advancements in the CyberKnife System's ability to track, detect and correct for movement in tumors due to respiration, more patients who previously had few treatment options now have access to a system that has been shown to improve their quality of life and may also extend their lives."

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife System is the world's first and only radiosurgery system that utilizes intelligent robotics to treat tumors anywhere in the body with sub-millimeter accuracy. The CyberKnife System treats patients in single or staged (typically 2-5) sessions by delivering multiple beams of precisely directed radiation that converge upon the tumor while minimizing injury to surrounding healthy tissue. Image guidance and computer controlled robotics combine to continuously track, detect and correct for tumor and patient movement throughout the treatment. Because of this extreme precision and accuracy, no head or body frame is required. The CyberKnife has proven to attract a new patient population to a physician's practice and complements existing radiation therapy, IMRT or IGRT programs.

About Accuray Inc.

Accuray Inc., a privately held company based in Sunnyvale, Calif., is the global leader in the field of robotic radiosurgery. Its CyberKnife System is the world's first and only intelligent robotic radiosurgery system designed to treat tumors anywhere in the body with sub-millimeter accuracy. More than 100 CyberKnife Systems have been purchased by leading medical centers throughout the world and a large body of peer-reviewed papers supports its clinical practice. To date, the CyberKnife has treated more than 20,000 patients worldwide. For more information, please visit

For media inquiries, please contact Ashley Greer at, 310-577-7870, ext. 125.

©2006 Accuray Incorporated. All rights reserved. Accuray, the Accuray logo, CyberKnife, Synchrony, Xsight and CyRIS are among trademarks or registered trademarks of Accuray Incorporated.

Source: Accuray

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.